Article info
PDFHighlights from this issue
Editors’ commentary
Citation
Editors’ commentary
Publication history
- Accepted April 25, 2023
- First published May 25, 2023.
Online issue publication
May 26, 2023
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ.
Other content recommended for you
- NOTCH2NLC-related disorders: the widening spectrum and genotype–phenotype correlation
- Clinical features of NOTCH2NLC-related neuronal intranuclear inclusion disease
- Genetic origin of sporadic cases and RNA toxicity in neuronal intranuclear inclusion disease
- Neuronal intranuclear inclusion disease
- Elderly woman with psychosis and unsteadiness
- Nitrous oxide-induced subacute combined degeneration of the cord: diagnosis and treatment
- Calcitonin gene-related peptide (CGRP) monoclonal antibodies for migraine
- Twelve-month efficacy of CGRP monoclonal antibodies and predictive value of short-term response: results of an Australian multicentre study
- Fremanezumab-associated injection site alopecia
- Neurogastroentrology: an A to Z